Effects of nerve growth factor on serum S100 and IL-6 in acute brain injury
10.3969/j.issn.1005-1678.2016.04.53
- VernacularTitle:神经生长因子对急性颅脑损伤患者血清S100β与IL－6的影响
- Author:
Xinghua LIU
;
Chunyou CHEN
;
Lin ZHENG
;
Xiaoguang XING
- Publication Type:Journal Article
- Keywords:
nerve growth factor;
acute brain injury;
S100β;
IL-6
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(4):167-169
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of nerve growth factor on the levels of serum S100 protein and interleukin-6 (IL-6) in patients with acute brain injury.Methods 70 cases with acute craniocerebral injury from March 2013 to May 2015 in department of cerebral surgery of Tianjin port hospital were selected and divided into two groups according to random number method.The control group (35 cases) received conventional symptomatic treatment, the study group (35 cases) received conventional treatment on the basis of mouse nerve growth factor for injection, with a consecutive treatment of two weeks.On admission, one and two weeks after admission, the Glasgow coma scale ( GCS) score was recorded, serum S100 beta protein and IL-6 levels were measured by enzyme-linked immunosorbent assay ( ELISA ) and the clinical curative effect of cerebral edema eliminate was compared.Results After two weeks’ treatment, the total efficacy in control group was lower than that in study group (77.14% vs.94.29%) ( P<0.05).The GCS score of two weeks after admission in study group was lower than that in control group, serum levels of neuron-specific enolase (NSE), myelin basic protein ( MBP) , S100βprotein and IL-6 of one and two weeks after admission in study group were lower than those in control group ( P<0.05).Conclusion The nerve growth factor could decrease the levels of serum S100βand IL-6 and alleviate inflammation in patients with acute craniocerebral injury and the effect is obvious.
